GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Respiri Ltd (ASX:RSH) » Definitions » DeferredTaxAndRevenue

Respiri (ASX:RSH) DeferredTaxAndRevenue : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Respiri DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Respiri's current deferred tax and revenue for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Respiri DeferredTaxAndRevenue Historical Data

The historical data trend for Respiri's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Respiri DeferredTaxAndRevenue Chart

Respiri Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.07

Respiri Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.07 -

Respiri DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Respiri's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Respiri (ASX:RSH) Business Description

Traded in Other Exchanges
Address
432 St Kilda Road, Level 9, Melbourne, VIC, AUS, 3004
Respiri Ltd is a company engaged in the research, development, and commercialization of medical devices and the production of mobile health applications for the management of asthma and related chronic respiratory diseases. It operates through the following segments: The Australia segment includes research, development, and commercialisation of medical devices, and the production of mobile health applications in Australia. The company generates revenue through Medical Devices Segment in Australia.

Respiri (ASX:RSH) Headlines

No Headlines